Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

This study has been completed.
Information provided by (Responsible Party):
Jeeyun Lee, Samsung Medical Center Identifier:
First received: November 7, 2011
Last updated: December 28, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)